Aldeyra Therapeutics
ALDX
ALDX
121 hedge funds and large institutions have $131M invested in Aldeyra Therapeutics in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 47 increasing their positions, 32 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
42% less capital invested
Capital invested by funds: $226M → $131M (-$94.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
121
Holding in Top 10
1
Calls
$1.4M
Puts
$103K
Top Buyers
| 1 | +$2.8M | |
| 2 | +$1.56M | |
| 3 | +$1.54M | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$1.43M |
| 5 |
D.E. Shaw & Co
New York
|
+$869K |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$3.17M | |
| 3 | -$1.41M | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$1.16M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$979K |